Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Dey

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Th9-endothelial cell crosstalk promotes inflammatory atherosclerotic cardiovascular diseaseIshita Baral, Yvonne Baumer, Aarohan Burma, et al.
Annals of the Rheumatic Diseases|December 13, 2025
Th9-arterial endothelial cell crosstalk promotes psoriatic atherosclerosisIshita Baral, Yvonne Baumer, Aarohan Mukerjhee Burma, et al.
Annals of the Rheumatic Diseases|August 1, 2022
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosusSarfaraz Hasni, Yenealem Temesgen-Oyelakin, Michael Davis, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Th9-endothelial cell crosstalk promotes inflammatory atherosclerotic cardiovascular diseaseIshita Baral, Yvonne Baumer, Aarohan Burma, et al.
Annals of the Rheumatic Diseases|December 13, 2025
Th9-arterial endothelial cell crosstalk promotes psoriatic atherosclerosisIshita Baral, Yvonne Baumer, Aarohan Mukerjhee Burma, et al.
Annals of the Rheumatic Diseases|August 1, 2022
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosusSarfaraz Hasni, Yenealem Temesgen-Oyelakin, Michael Davis, et al.
Pageof 4